NCT02220491View on ClinicalTrials.gov

Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2014

Primary Completion Date

May 18, 2020

Study Completion Date

May 18, 2020

Conditions
Brain Metastases
Interventions
RADIATION

Single-fraction radiotherapy

Volumetric modulated arc therapy (VMAT) delivering 15 Gy in one fraction to brain metastases

RADIATION

Whole-brain radiotherapy

Whole brain radiotherapy delivering 20 Gy in five fractions to brain metastases

Trial Locations (1)

V5Z 4E6

British Columbia Cancer Agency, Vancouver

All Listed Sponsors
lead

British Columbia Cancer Agency

OTHER

NCT02220491 - Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases | Biotech Hunter | Biotech Hunter